On Sunday April 11th and Monday April 12th, Guidepoint Insights will be hosting a series of 50-minute virtual group meetings featuring KOLs who will dive deeper into AACR (American Association for Cancer Research) clinical data updates.


To request access to AACR group meetings, complete the form below.


    Sunday, April 11th

    9:00 AM ET - Ryan Corcoran

    • Gastrointestinal Cancers, BRAF pathway, KRAS Tumor Targets pathways, CD40 Targeting | Associate Professor at Harvard Medical School

    11:00 AM ET - Poulikos Poulikakos

    • Targeted Protein Inhibition and Degradation in the RAS/RAF/MEK/ERK Pathway | Assistant Professor at Icahn School of Medicine at Mount Sinai

    12:00 PM ET - Jason Luke

    • Novel Immunotherapeutics | Director of Immunotherapeutics Center at UPMC Hillman Cancer Center

    1:00 PM ET - Channing Der

    • RAS-Targeted Therapeutics |Professor at University of North Carolina At Chapel Hill

    2:00 PM ET - Jared Weiss

    • Lung Cancer Targets Ft. TIGIT, and Exon 20 | Associate Professor of Medicine, Division of Oncology at University of North Carolina At Chapel Hill

    Monday, April 12th

    9:10 AM ET - Timothy Yap

    • Bringing Synthetic Lethality into the Clinic | Medical Director at The University of Texas MD Anderson Cancer Center

    12:00 PM ET - Adil Daud

    • Novel Immunotherapeutics | Director of Melanoma Clinical Research and Director of the Melanoma Program at The University of California, San Francisco

    1:00 PM ET - Michael Morse

    • Plk1 inhibitors, KRAS mutations, Pancreatic Cancer, CD40 Targeting| Professor at Duke University Health System, Inc.


    AACR meetings will not be recorded and transcripts will not be available after the event. To recreate conditions similar to an in-person meeting, this event will be conducted as a Zoom meeting. As such, participants will be able to see/identify each other.